The Ministry of Economy, Trade and Industry (METI) and The Japan External Trade Organization (JETRO), co-organising with Singapore government agencies, held the first “Singapore-Japan Fast Track Pitch Event” in Singapore to accelerate global open innovation of Japanese companies and startups on April 20, 2023. We participated as a Challenge Owner and solicited proposals from startup companies with the challenge to co-create services that can enable expanded scope of point of...
Allm Inc. established Allm SEA sdn. bhd. in early 2021 to provide solutions to improve the healthcare industry in the Southeast Asia region. The company is already in talks with medical institutions in Malaysia including public hospitals, seeking partnerships to connect its solutions with products from the healthcare industry in the country. Allm Inc. CEO Teppei Sakano talked about Allm's solutions and their missions in an interview with the New...
Tokyo, Japan (July 5, 2022) - Allm Inc. is pleased to announce that it has raised 24.7 billion yen through a third-party allotment of new shares to DeNA Co., Ltd. and SEIBU REALTY SOLUTIONS INC. Allm will use the funds to accelerate DX in the medical and nursing care field by developing new solutions specialized in telemedicine and connecting existing solutions with IoT devices. In addition, the company aims to...
Paper on remote surgical support service using Join, "Remote neuro-endovascular consultation using a secure telemedicine system: A feasibility study" has been published in Surgical Neurology International. Remote consultation for surgery was conducted between The Jikei University Hospital and Neurosurgery Higashiyokohama Hospital through voice communication over a web conferencing system while live streaming video from angiography and operating room (OR) cameras were viewed via Join. It was concluded that this system...
Join has been introduced as an app enables to share medical images using smartphones on Life Science Matching Initiative Platform. Learn more
Allm provides an infectious disease control solution "MyPass" for "Vaccinations and Testing Information" demonstration at public events, aiming to realize a digital health passport using Allm’s MySOS Tokyo, Japan (Oct. 20th, 2021) - Allm Inc. is pleased to announce that it will provide the infectious disease control solution "MyPass" developed by Allm for the government's technological demonstration of a "vaccination and testing information" for large-scale events. [caption id="attachment_1757" align="aligncenter" width="1500"]...
Our CEO Sakano talked about an infectious disease control solution "MyPass", to hold large-scale events in an interview with Billboard Japan. Learn more
Tokyo, Japan (5th April 2021) - Allm Inc. is pleased to announce its close of an approximately 5.6 billion yen Series A financing round. The series was led by Sompo Holdings, Inc., MITSUI & CO., LTD., Eisai Co., Ltd., Royal Philips, Nippon Information Development Co., Ltd., CYBERDYNE, INC., FINANCIAL AGENCY, Inc., mixi, Inc., Capital Medica Co.,Ltd., Vector Inc., SBI Investment Co., Ltd., Bonds Investment Group, Mizuho Capital Corp., Asia Africa...
The study published in February 2021 further validated how our clinical communication solution, Join, helped improve statistically significant clinical outcomes, such as door-to-needle, door-to-puncture, and door-to-reperfusion times. These times were reduced by up to 35%. The 90-day mortality rate was decreased by 85%. Learn more
Join won 2020 Nikkei Superior Products and Services Awards 'Nikkei Business Daily Awards'. 2020 Nikkei Superior Products and Services Awards
